Citation

Grandinetti CA. Pharm Times 2008; 74(2): 31-33.

Copyright

(Copyright © 2008, Pharmacy Times)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; nephrotoxicity; insomnia; liver failure; suicidal ideation; depression; anxiety; suicide attempt; liver transplantation; patient education; lamivudine; fatigue; article; vomiting; antidepressant agent; weight reduction; clinical feature; serotonin uptake inhibitor; patient care; patient monitoring; headache; paracetamol; interferon; diarrhea; nausea; drug withdrawal; diphenhydramine; hepatitis C; irritability; fever; combination chemotherapy; side effect; alopecia; hepatitis; anemia; flu like syndrome; Hepatitis C virus; myalgia; pruritus; ribavirin; alanine aminotransferase; drug half life; liver cancer; mental instability; drug elimination; coughing; liver cirrhosis; hepatitis B; hemolytic anemia; malaise; teratogenicity; monotherapy; drug eruption; peginterferon; peginterferon alpha2a; peginterferon alpha2b; Hepatitis B virus; entecavir; drug dose reduction; neuropathy; nose congestion; chill; treatment duration; alanine aminotransferase blood level; erythropoietin; lifestyle modification; bedtime dosage; hepatitis B(e) antigen; adefovir; hepatitis B surface antigen; musculoskeletal pain; nucleoside derivative